litlas
Log inCreate account

Vincenzo Bronte

Active 1989–2024

124
Papers
38,257
Citations
94
h-index
121
i10-index

Citations

Citations per year for Vincenzo Bronte1990: 3 citations1991: 11 citations1992: 11 citations1993: 9 citations1994: 10 citations1995: 13 citations1996: 36 citations1997: 50 citations1998: 42 citations1999: 48 citations2000: 61 citations2001: 49 citations2002: 44 citations2003: 64 citations2004: 75 citations2005: 165 citations2006: 181 citations2007: 289 citations2008: 351 citations2009: 372 citations2010: 392 citations2011: 419 citations2012: 537 citations2013: 592 citations2014: 545 citations2015: 596 citations2016: 693 citations2017: 687 citations2018: 706 citations2019: 1,624 citations2020: 2,021 citations2021: 2,177 citations2022: 1,605 citations2023: 1,057 citations2024: 1,406 citations2025: 730 citations2026: 22 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,368 citing papers, 27% of this breakdownChina: 3,119 citing papers, 19.2% of this breakdownItaly: 977 citing papers, 6% of this breakdownGermany: 879 citing papers, 5.4% of this breakdownUnited Kingdom: 718 citing papers, 4.4% of this breakdownFrance: 526 citing papers, 3.2% of this breakdownJapan: 467 citing papers, 2.9% of this breakdownNetherlands: 367 citing papers, 2.3% of this breakdownCanada: 349 citing papers, 2.2% of this breakdownAustralia: 326 citing papers, 2% of this breakdownSpain: 300 citing papers, 1.9% of this breakdownSouth Korea: 293 citing papers, 1.8% of this breakdown
0%27%Other 21.7%

Institutions

Fields

  • Immunology and Microbiology40.2%
  • Medicine33.3%
  • Biochemistry, Genetics and Molecular Biology19.6%
  • Neuroscience2.4%
  • Engineering2.2%
  • Materials Science0.6%
  • Other1.7%

Topics

  • Immune cells in cancer13%
  • Cancer Immunotherapy and Biomarkers7.9%
  • Immune Cell Function and Interaction6.2%
  • Immunotherapy and Immune Responses6.1%
  • Immune Response and Inflammation2.6%
  • CAR-T cell therapy research2.3%
  • Other61.9%

Coauthors

All papers

Open in search
  1. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

    Authors: Vincenzo Bronte, Sven Brandau, Shu‐Hsia Chen, Mario P. Colombo, Alan B. Frey, Tim F. Greten, Susanna Mandruzzato, Peter J. Murray, Augusto C. Ochoa, Suzanne Ostrand‐Rosenberg, Paulo C. Rodrı́guez, Antonio Sica, Viktor Umansky, Robert H. Vonderheide, Dmitry I. Gabrilovich - Nature Communications 2016 cited by 2,721

  2. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

    Authors: Muhammad Zaeem Noman, Giacomo Desantis, Bassam Janji, Meriem Hasmim, Saoussen Karray, Philippe Dessen, Vincenzo Bronte, Salem Chouaı̈b - The Journal of Experimental Medicine 2014 cited by 2,132

  3. Coordinated regulation of myeloid cells by tumours

    Authors: Dmitry I. Gabrilovich, Suzanne Ostrand‐Rosenberg, Vincenzo Bronte - Nature reviews. Immunology 2012 cited by 3,520

  4. The Spleen in Local and Systemic Regulation of Immunity

    Authors: Vincenzo Bronte, Mikaël J. Pittet - Immunity 2013 cited by 1,054

  5. Regulation of immune responses by L-arginine metabolism

    Authors: Vincenzo Bronte, Paola Zanovello - Nature reviews. Immunology 2005 cited by 1,742

  6. Monocytes in the Tumor Microenvironment

    Authors: Stefano Ugel, Stefania Canè, Francesco De Sanctis, Vincenzo Bronte - Annual Review of Pathology Mechanisms of Disease 2021 cited by 334

  7. The Terminology Issue for Myeloid-Derived Suppressor Cells

    Authors: Dmitry I. Gabrilovich, Vincenzo Bronte, Shu‐Hsia Chen, Mario P. Colombo, Augusto C. Ochoa, Suzanne Ostrand‐Rosenberg, Hans Schreiber - Cancer Research 2007 cited by 812

  8. Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages

    Authors: Stefano Ugel, Francesco De Sanctis, Susanna Mandruzzato, Vincenzo Bronte - Journal of Clinical Investigation 2015 cited by 559

  9. Immune suppressive mechanisms in the tumor microenvironment

    Authors: David H. Munn, Vincenzo Bronte - Current Opinion in Immunology 2015 cited by 524

  10. Altered macrophage differentiation and immune dysfunction in tumor development

    Authors: Antonio Sica, Vincenzo Bronte - Journal of Clinical Investigation 2007 cited by 1,235

  11. A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells

    Authors: Giada Mondanelli, Roberta Bianchi, Maria Teresa Pallotta, Ciriana Orabona, Elisa Albini, Alberta Iacono, Maria Laura Belladonna, Carmine Vacca, Francesca Fallarino, Antonio Macchiarulo, Stefano Ugel, Vincenzo Bronte, Federica Gevi, Lello Zolla, Auke P. Verhaar, Maikel P. Peppelenbosch, Emilia Maria Cristina Mazza, Silvio Bicciato, Yasmina Laouar, Laura Santambrogio, Paolo Puccetti, Claudia Volpi, Ursula Grohmann - Immunity 2017 cited by 343

  12. Neutralization of NET-associated human ARG1 enhances cancer immunotherapy

    Authors: Stefania Canè, Roza Maria Barouni, Marina Fabbi, John W. Cuozzo, Giulio Fracasso, Annalisa Adamo, Stefano Ugel, Rosalinda Trovato, Francesco De Sanctis, Mauro Giacca, Rita T. Lawlor, Aldo Scarpa, Borislav C. Rusev, Gabriella Lionetto, Salvatore Paiella, Roberto Salvia, Claudio Bassi, Susanna Mandruzzato, Silvano Ferrini, Vincenzo Bronte - Science Translational Medicine 2023 cited by 100

  13. Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade

    Authors: Nicolas Jacquelot, Takahiro Yamazaki, María P. Roberti, Connie P.M. Duong, Miles C. Andrews, Loïc Verlingue, Gladys Ferrere, Sonia Becharef, Marie Vétizou, Romain Daillère, Meriem Messaoudene, David Enot, Gautier Stoll, Stefano Ugel, Ilaria Marigo, Shin Foong Ngiow, Aurélien Marabelle, Armelle Prévost‐Blondel, Pierre-Olivier Gaudreau, Vancheswaran Gopalakrishnan, Alexander Eggermont, Paule Opolon, Christophe Klein, Gabriele Madonna, Paolo A. Ascierto, Antje Sucker, Dirk Schadendorf, Mark J. Smyth, Jean‐Charles Soria, Guido Kroemer, Vincenzo Bronte, Jennifer A. Wargo, Laurence Zitvogel - Cell Research 2019 cited by 248

  14. Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor

    Authors: Ilaria Marigo, Erika Bosio, Samantha Solito, Circe Mesa, Audry Fernández, Luigi Dolcetti, Stefano Ugel, Nada Sonda, Silvio Bicciato, Erika Falisi, Fiorella Calabrese, Giuseppe Basso, Paola Zanovello, Emanuele Cozzi, Susanna Mandruzzato, Vincenzo Bronte - Immunity 2010 cited by 845

  15. Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function

    Authors: Paolo Serafini, Kristen F. Meckel, Michael J. Kelso, Kimberly Noonan, Joseph A. Califano, Wayne M. Koch, Luigi Dolcetti, Vincenzo Bronte, Ivan Borrello - The Journal of Experimental Medicine 2006 cited by 754

  16. Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells

    Authors: Barbara Molon, Stefano Ugel, Federica Del Pozzo, Cristiana Soldani, Serena Zilio, Debora Avella, Antonella De Palma, Pierluigi Mauri, Ana Monegal, María Rescigno, Benedetta Savino, Piergiuseppe Colombo, Nives Jonjić, Sanja Pečanić, Loretta Lazzarato, Roberta Fruttero, Alberto Gasco, Vincenzo Bronte, Antonella Viola - The Journal of Experimental Medicine 2011 cited by 633

  17. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

    Authors: Rosalinda Trovato, Alessandra Fiore, S Sartori, Stefania Canè, Rosalba Giugno, Luciano Cascione, Salvatore Paiella, Roberto Salvia, Francesco De Sanctis, Ornella Poffe, Cristina Anselmi, Francesca Hofer, Silvia Sartoris, Geny Piro, Carmine Carbone, Vincenzo Corbo, Rita T. Lawlor, Samantha Solito, Laura Pinton, Susanna Mandruzzato, Claudio Bassi, Aldo Scarpa, Vincenzo Bronte, Stefano Ugel - Journal for ImmunoTherapy of Cancer 2019 cited by 187

  18. GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment

    Authors: Marie Jo Halaby, Kebria Hezaveh, Sara Lamorte, M. Teresa Ciudad, Andreas Kloetgen, Bethany MacLeod, Mengdi Guo, Ankur Chakravarthy, Tiago da Silva Medina, Stefano Ugel, Aristotelis Tsirigos, Vincenzo Bronte, David H. Munn, Trevor J. Pugh, Daniel D. De Carvalho, Marcus O. Butler, Pamela S. Ohashi, David G. Brooks, Tracy L. McGaha - Science Immunology 2019 cited by 186

  19. Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism

    Authors: Alessandra Mazzoni, Vincenzo Bronte, Alberto Visintin, Jessica H. Spitzer, Elisa Apolloni, Paolo Serafini, Paola Zanovello, David M. Segal - The Journal of Immunology 2002 cited by 681

  20. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling

    Authors: Viktor Fleming, Xiaoying Hu, Céline Weller, Rebekka Weber, Christopher Groth, Zeno Riester, Laura Hüser, Qian Sun, Vasyl S. Nagibin, Carsten J. Kirschning, Vincenzo Bronte, Jochen Utikal, Peter Altevogt, Viktor Umansky - Cancer Research 2019 cited by 132

  21. Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs

    Authors: Chiara Porta, Francesca Maria Consonni, Sara Morlacchi, Sabina Sangaletti, Augusto Bleve, Maria Grazia Totaro, Paola Larghi, Monica Rimoldi, Claudio Tripodo, Laura Strauss, Stefania Banfi, Mariangela Storto, Tiziana Pressiani, Lorenza Rimassa, Silvia Tartari, Alessandro Ippolito, Andrea Doni, Giulia Soldà, Stefano Duga, Viviana Piccolo, Renato Ostuni, Gioacchino Natoli, Vincenzo Bronte, Fiorella Balzac, Emilia Turco, Emilio Hirsch, Mario P. Colombo, Antonio Sica - Cancer Research 2020 cited by 122

  22. Understanding Local Macrophage Phenotypes In Disease: Modulating macrophage function to treat cancer

    Authors: Vincenzo Bronte, Peter J. Murray - Nature Medicine 2015 cited by 186

  23. L-arginine metabolism in myeloid cells controls T-lymphocyte functions

    Authors: Vincenzo Bronte, Paolo Serafini, Alessandra Mazzoni, David M. Segal, Paola Zanovello - Trends in Immunology 2003 cited by 585

  24. Hierarchy of immunosuppressive strength among myeloid‐derived suppressor cell subsets is determined by GM‐CSF

    Authors: Luigi Dolcetti, Elisa Peranzoni, Stefano Ugel, Ilaria Marigo, Audry Fernández, Circe Mesa, Markus Geilich, Gregor Winkels, Elisabetta Traggiai, Anna Casati, Fabio Grassi, Vincenzo Bronte - European Journal of Immunology 2009 cited by 566